CA3199545A1 - Compositions and methods for the treatment of hypertension - Google Patents
Compositions and methods for the treatment of hypertensionInfo
- Publication number
- CA3199545A1 CA3199545A1 CA3199545A CA3199545A CA3199545A1 CA 3199545 A1 CA3199545 A1 CA 3199545A1 CA 3199545 A CA3199545 A CA 3199545A CA 3199545 A CA3199545 A CA 3199545A CA 3199545 A1 CA3199545 A1 CA 3199545A1
- Authority
- CA
- Canada
- Prior art keywords
- weight
- oil
- carriers
- cbd
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/857,991 | 2022-07-05 | ||
| US17/857,985 US11666544B1 (en) | 2022-07-05 | 2022-07-05 | Compositions and methods for treating hypertension |
| US17/857,985 | 2022-07-05 | ||
| US17/857,991 US11980593B2 (en) | 2022-07-05 | 2022-07-05 | Compositions and methods for treating hypertension |
| PCT/US2023/019789 WO2024010629A1 (en) | 2022-07-05 | 2023-04-25 | Compositions and methods for treating hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3199545A1 true CA3199545A1 (en) | 2025-01-31 |
Family
ID=89453914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3199545A Pending CA3199545A1 (en) | 2022-07-05 | 2023-04-25 | Compositions and methods for the treatment of hypertension |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4346802A4 (de) |
| JP (1) | JP7823052B2 (de) |
| AU (1) | AU2023237124A1 (de) |
| CA (1) | CA3199545A1 (de) |
| MX (1) | MX2023011494A (de) |
| WO (1) | WO2024010629A1 (de) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3283065A4 (de) * | 2015-12-09 | 2018-12-26 | Poviva Tea, LLC | Verfahren zur formulierung oral einnehmbarer zusammensetzungen mit lipophilen wirkstoffen |
| JP6893012B2 (ja) * | 2017-07-18 | 2021-06-23 | 徳義制薬有限公司Deyi Pharmarmaceutical Ltd. | 肺高血圧症の治療におけるカンナビジオールの応用 |
| US20200315965A1 (en) * | 2019-04-02 | 2020-10-08 | Cannasol Technologies, Llc | Nanoemulsion concentrate formulations and methods |
| JP2022533837A (ja) * | 2019-05-20 | 2022-07-26 | ポビバ コーポレーション | 生物活性物質と胆汁酸塩を含む組成物 |
| JP2021031485A (ja) * | 2020-02-06 | 2021-03-01 | 株式会社中島商会 | Cbdオイルの製造方法 |
| US20210299062A1 (en) * | 2020-03-29 | 2021-09-30 | Mark J. Rosenfeld | Cannabinoid compositions and methods of treatment |
| CA3172889C (en) * | 2020-04-20 | 2024-05-28 | John Docherty | Compositions and methods for enhanced delivery of antiviral agents |
| CN114177163B (zh) * | 2022-01-12 | 2023-05-02 | 刘树民 | 一种治疗高血压的药物 |
-
2023
- 2023-04-25 EP EP23723801.9A patent/EP4346802A4/de active Pending
- 2023-04-25 JP JP2023536335A patent/JP7823052B2/ja active Active
- 2023-04-25 MX MX2023011494A patent/MX2023011494A/es unknown
- 2023-04-25 AU AU2023237124A patent/AU2023237124A1/en active Pending
- 2023-04-25 CA CA3199545A patent/CA3199545A1/en active Pending
- 2023-04-25 WO PCT/US2023/019789 patent/WO2024010629A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP7823052B2 (ja) | 2026-03-03 |
| MX2023011494A (es) | 2024-01-18 |
| EP4346802A1 (de) | 2024-04-10 |
| AU2023237124A1 (en) | 2024-01-25 |
| JP2024528761A (ja) | 2024-08-01 |
| WO2024010629A1 (en) | 2024-01-11 |
| EP4346802A4 (de) | 2024-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11666544B1 (en) | Compositions and methods for treating hypertension | |
| US11666543B1 (en) | Pharmaceutical compositions and methods for treating hypertension | |
| US6245326B1 (en) | Health supplement | |
| JP6073998B2 (ja) | 粘土組成物 | |
| FR2673812A1 (fr) | Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications. | |
| CN103889246A (zh) | 诱导产生饱腹感的方法和组合物 | |
| KR102419759B1 (ko) | 고 약물 부하량의 중쇄 트리글리세라이드를 갖는 약학 조성물 및 이와 관련된 방법 | |
| CN105073129A (zh) | 用于糖尿病的口服治疗的药物组合物 | |
| US12220422B1 (en) | Compositions and methods for treating epilepsy | |
| CN112426403A (zh) | 一种口腔溃疡凝胶及其制备方法和应用 | |
| CA3173107A1 (en) | Composition comprising antimicrobial agent and its uses | |
| AU2023302884B2 (en) | Pharmaceutical compositions and methods for treating hypertension | |
| US11980593B2 (en) | Compositions and methods for treating hypertension | |
| CA3199545A1 (en) | Compositions and methods for the treatment of hypertension | |
| WO2024010628A1 (en) | Pharmaceutical compositions and methods for treating hypertension | |
| US20240009140A1 (en) | Pharmaceutical compositions and methods for treating hypertension | |
| JP2005528353A (ja) | 糖尿病に関連する症状及び糖尿病の合併症を包含する糖尿病の治療方法 | |
| FR2882933A1 (fr) | Utilisation d'un extrait d'oignon pour la fabrication d'une composition pour controler la prise de poids | |
| JPS63215640A (ja) | 易吸収性抗炎症剤及びその製造方法 | |
| US20250032516A1 (en) | Compositions and methods for treating epilepsy | |
| JPS6260369B2 (de) | ||
| CN108201541A (zh) | 富勒烯结构在制备增强胰岛素敏感性的药物中的应用 | |
| AU747388B2 (en) | Health supplement | |
| EP2478902A1 (de) | Pharmazeutische zusammensetzung zur gewichtsreduktion und verfahren zu ihrer herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| Q12 | Application published |
Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION PUBLISHED (OPEN TO PUBLIC INSPECTION) Effective date: 20250131 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251010 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251110 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251110 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260225 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260225 |